2Bertolini V,Chiaravalli AM,Klersy C,et al.Gastrointestinalstromal tumors-frequency,malignancy,and new prognosticfactors:the experience of a single institution[J].Pathol ResPract,2008,204(4):219-233.
4Hadithi M, Heine GD, Jacobs MA, et al. A prospective study compa- ring video capsule endoscopy with double-balloon enteroscopy in patients with obscure gastrointestinal bleeding [ J]. Am J Gastroenterol,2006, 101 (1) : 52-57.
5Ghanem N, Altehoefer C, Furtwangler A, et al. Computed tomography in gastrointestinal stromal tumors [ J]. Eur Radiol, 2003, 13 (7) : 1669-1679.
6Scaife CI, Hunt KK, Patel SR, et al. Is there a role for surgery in patients with "unresectable" C kit + gastrointestinal stromal tumors treated with imatinib mesylate [J]? Am J Surg, 2003, 186 (6):665 -669.
7Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal strimal tumors: a consensus approach [J]. Intl J Surg Pathol, 2002, 10(2) : 81-89.
8Vou Mehren M. New therapeutic Strategies for soft tissue sarcomas [J]. Curr Treat Options Oncol, 2003, 4{6): 441-451.
9Blanke C, Eisenberg BL, Heeinrich M. Epidemiology of GIST [J]. Am J Gastroenterol, 2005, 100(10) : 2336-2374.
10Nilsson B, Bumming P, Meis-Kindblom JM, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-apopulation-based study in Western Sweden [J]. Cancer, 2005, 103(4): 821-829.
